Biotechnology firm managers are no strangers to uncertainty. Uncertainty surrounding the potential payoff of an investment is common for most businesses; but biotech firms are also faced with uncertainty regarding the development of an investment. The time a new biotechnology takes to progress through the development pipeline, the costs involved, and the regulatory approval process...

Alzheimer’s Australia commissioned NATSEM to estimate the cost of dementia in Australia. The economic impact of dementia is a major concern nationally and internationally as the number of individuals with dementia continues to rise.

This paper discusses the use of secondments as a tool to increase knowledge translation between academics and policy makers by developing individual capacity.

Background: Prescription drug abuse is a rising problem in Australia and pharmaceutical drugs have been the most frequent contributors to overdose deaths in Victoria in recent years. Objective/s: The objectives of this article are to examine the main prescription drugs contributing to overdose deaths and to consider how doctors may help in reducing this problem...

This demonstration data linkage study investigates the use of lung function testing in the diagnosis and management of chronic airways disease. It uses data from the 45 and Up Study linked to Medicare Benefits Schedule (MBS) and Pharmaceutical Benefits Scheme (PBS) data. The study shows that: - contrary to recommended guidelines, most study participants (82%)...